Search

everythinglearnresearchcommunity

for

Search:↓

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

The new face mask with Eflornithine can potentially reduce facial hair growth and moisturize skin.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Three specific genetic variants cause severe skin issues in children with EBS, highlighting the need for early genetic screening.

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Zinc pyrithione dissolves quickly on the skin and in hair follicles, especially in smaller particles.

Ritlecitinib works well and is safe for treating alopecia areata.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The lotion safely and effectively reduces unwanted hair growth.

Alitretinoin may help treat alopecia areata.